Written Question·Department of Health and Social Care·UIN 20534

Pancreatic Enzyme Replacement Therapy

Tabled: 16 December 2024

Answered: 19 December 2024

Named Day

Question

Mike Martin

To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of supply chain issues surrounding the importing of Creon into the United Kingdom on patients with pancreatic diseases; and what steps he is taking to incr

Answer

Karin Smyth

The Department has been working with suppliers to address the current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy (PERT) used by patients with conditions such as cystic fibrosis and certain cancers, including pancre...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 20534) →